|
|
|
March 28, 2008
Series A Financing Funds Spinout of TriVascular from Boston Scientific
TriVascular2 is developing a minimally invasive stent graft device for the treatment of aortic aneurysms. The company’s predecessor, TriVascular, Inc., was acquired by Boston Scientific in 2005. TriVascular2 recently completed a $65mn Series A financing as part of its spinout from Boston Scientific. Read more here.
--------------------------------
Back to News
|
|
| |
